Literature DB >> 35919312

Temporal retinal thinning might be an early diagnostic indicator in male pediatric X-linked Alport syndrome.

Rui-Lin Zhu1, Liang Zhao1, Xiao-Peng Gu1, Ya-Di Zhang1, Fang Wang2, Yan-Qin Zhang2, Liu Yang1.   

Abstract

AIM: To evaluate temporal retinal thinning changes in retinal layers using spectral-domain optical coherence tomography (SD-OCT) in pediatric X-linked Alport syndrome (XLAS) patients.
METHODS: A retrospective case-control study. SD-OCT scans of pediatric patients diagnosed with XLAS and age- and sex-matched healthy control participants were reviewed. Automated segmentation of SD-OCT scans was induced to analyze the retinal thickness (RT) of different layers. The temporal thinning index (TTI) was calculated for each layer and compared between the patients and the control group.
RESULTS: Forty-three pediatric XLAS patients and 60 healthy controls were included. Temporal retinal thinning was present in 33 patients (76.74%), while 28 patients (65.11%) had severe pathological temporal retinal thinning and 5 patients (11.63%) had moderate thinning. The temporal inner sector RT (P<0.0001), the temporal outer sector RT (P<0.0001), and the nasal outer sector RT (P=0.0211) were significantly thinner in the XLAS male patients. The TTI of the total retina was significantly higher in the XLAS group than in the control group (P<0.0001). The TTI of the inner retina layers (P<0.0001), ganglion cell layer (P<0.0001), inner plexiform layer (P<0.0001), inner nuclear layer (P<0.0001), and outer nuclear layer (P<0.0001) were significantly higher in the XLAS group. The central RT of the XLAS group was significantly thinner than that of the control group (P<0.0001).
CONCLUSION: Temporal retinal thinning appears early in XLAS patients, especially in male patients. The thinning is mainly caused by structural abnormalities of the inner retina. This suggests that temporal retinal thinning could be helpful for the early diagnosis and follow-up of XLAS with noninvasive SD-OCT examination. International Journal of Ophthalmology Press.

Entities:  

Keywords:  Alport syndrome; retinal thickness; segmentation; spectral domain optical coherence tomography

Year:  2022        PMID: 35919312      PMCID: PMC9318094          DOI: 10.18240/ijo.2022.07.15

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.645


  29 in total

1.  Ocular manifestations of Alport syndrome.

Authors:  Jian-Min Xu; Shi-Sheng Zhang; Qiong Zhang; Ying-Ming Zhou; Cai-Hong Zhu; Jian Ge; Ling Wang
Journal:  Int J Ophthalmol       Date:  2010-06-18       Impact factor: 1.779

2.  Structure-function correlation of focal and diffuse temporal perifoveolar thinning in Alport syndrome.

Authors:  Evan N Wong; Mei-Ling Tay-Kearney; Fred K Chen
Journal:  Clin Exp Ophthalmol       Date:  2013-10-23       Impact factor: 4.207

3.  Alport syndrome with bilateral simultaneous anterior and posterior lenticonus with severe temporal macular thinning.

Authors:  Vinita Gupta; Mahsa Jamil; Saurabh Luthra; Athul S Puthalath
Journal:  BMJ Case Rep       Date:  2019-08-15

4.  Normal Reference Ranges of Optical Coherence Tomography Parameters in Children.

Authors:  Silviya Krumova; Nelly Sivkova; Vassil Marinov; Desislava Koleva-Georgieva; Desislava Voynikova
Journal:  Folia Med (Plovdiv)       Date:  2020-06-30

Review 5.  Alport syndrome--insights from basic and clinical research.

Authors:  Jenny Kruegel; Diana Rubel; Oliver Gross
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

6.  Normative reference ranges for the retinal nerve fiber layer, macula, and retinal layer thicknesses in children.

Authors:  Susan E Yanni; Jingyun Wang; Christina S Cheng; Kelly I Locke; Yuquan Wen; David G Birch; Eileen E Birch
Journal:  Am J Ophthalmol       Date:  2012-11-03       Impact factor: 5.258

7.  Temporal macular thinning associated with X-linked Alport syndrome.

Authors:  Faisal Ahmed; Kandon K Kamae; Denise J Jones; Margaret M Deangelis; Gregory S Hageman; Martin C Gregory; Paul S Bernstein
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

8.  A triad of retinal signs in Alport syndrome: The 'stair-case' fovea, choroidal thinning and peripheral schisis.

Authors:  N J Ghadiri; N Stanojcic; Msa Raja; B J Burton
Journal:  Eur J Ophthalmol       Date:  2019-04-07       Impact factor: 2.597

9.  Clinical utility gene card for: Alport syndrome - update 2014.

Authors:  Jens Michael Hertz; Mads Thomassen; Helen Storey; Frances Flinter
Journal:  Eur J Hum Genet       Date:  2014-11-12       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.